Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 4Lymphoid 4Myeloid 2Plasma cell 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Blast Crisis 1Anemia, Aplastic 1

Interventions

Cyclophosphamide 34Peripheral Blood Stem Cell Transplantation 31fludarabine phosphate 27Tacrolimus 24Busulfan 24Antilymphocyte Serum 22Mycophenolic Acid 19Methotrexate 17Cyclosporine 17Radiotherapy 14Filgrastim 14Whole-Body Irradiation 13Methylprednisolone 13Cord Blood Stem Cell Transplantation 11Melphalan 9Flow Cytometry 9Etoposide 9Therapeutics 8Sirolimus 6Psychiatric Rehabilitation 6Polymerase Chain Reaction 6Granulocyte Colony-Stimulating Factor 6sargramostim 5Prednisone 4Cytarabine 4Carboplatin 4fludarabine 3Thiotepa 3Ondansetron 3Leucovorin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Blast Crisis × CT-P10 × Plasma cell × Clear all
NCT02960646 2023-02-16

Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
11 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Anemia, Aplastic, Blast Crisis, Hodgkin Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡